Betaxolol
Betoptic, Kerledex (betaxolol) is a small molecule pharmaceutical. Betaxolol was first approved as Betoptic on 1985-08-30. It is used to treat hypertension and open-angle glaucoma in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target beta-2 adrenergic receptor.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Betoptic (generic drugs available since 1999-10-22, discontinued: Kerlone)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Betaxolol hydrochloride
Betaxolol hydrochloride
+
Chlorthalidone
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
KERLEDEX | Sanofi | N-019807 DISCN | 1992-10-30 | 2 products |
Hide discontinued
Betaxolol hydrochloride
+
Pilocarpine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BETOPTIC PILO | Alcon Research | N-020619 DISCN | 1997-04-17 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
betaxolol hydrochloride | NDA authorized generic | 2022-09-30 |
betoptic s | New Drug Application | 2023-02-02 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hypertension | EFO_0000537 | D006973 | I10 |
open-angle glaucoma | EFO_0004190 | D005902 | H40.1 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
— C07: Beta-adrenergic blocking agents
— C07A: Beta blocking agents
— C07AB: Beta blocking agents, selective
— C07AB05: Betaxolol
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01E: Antiglaucoma preparations and miotics
— S01ED: Beta blocking agents, antiglaucoma preparations and miotics
— S01ED02: Betaxolol
— S01ED52: Betaxolol, combinations
HCPCS
No data
Clinical
Clinical Trials
19 clinical trials
View more details

Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cataract | D002386 | EFO_0001059 | H26.9 | 1 | — | — | 2 | — | 3 |
Cataract extraction | D002387 | 1 | — | — | 1 | — | 2 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bacterial conjunctivitis | D003234 | EFO_1000829 | H10.0 | — | 2 | 6 | — | — | 7 |
Keratitis | D007634 | H16 | — | — | 1 | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 2 | — | — | — | — | 2 | ||
Lacrimal duct obstruction | D007767 | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | BETAXOLOL |
INN | betaxolol |
Description | Betaxolol is a propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure. It has a role as a beta-adrenergic antagonist, an antihypertensive agent and a sympatholytic agent. |
Classification | Small molecule |
Drug class | beta-blockers (propranolol type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1 |
Identifiers
PDB | — |
CAS-ID | 63659-18-7 |
RxCUI | 1520 |
ChEMBL ID | CHEMBL423 |
ChEBI ID | 3082 |
PubChem CID | 2369 |
DrugBank | DB00195 |
UNII ID | O0ZR1R6RZ2 (ChemIDplus, GSRS) |
Target
Agency Approved
Alternate
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,459 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
517 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more